Stavudine and Alpha 1 foetoprotein increased - a phase IV clinical study of FDA data

Summary:

Alpha 1 foetoprotein increased is reported as a side effect among people who take Stavudine (stavudine), especially for people who are male, 30-39 old, also take Didanosine,.

The phase IV clinical study analyzes which people have Alpha 1 foetoprotein increased when taking Stavudine. It is created by eHealthMe based on reports of 10,313 people who have side effects when taking Stavudine from the FDA, and is updated regularly.

What is Stavudine?

Stavudine has active ingredients of stavudine. eHealthMe is studying from 10,319 Stavudine users. Check the latest studies of Stavudine.

What is Alpha 1 foetoprotein increased?

Alpha 1 foetoprotein increased is found to be associated with 121 drugs and 205 conditions by eHealthMe. Check the latest studies of Alpha 1 foetoprotein increased.



On Jul, 15, 2026

10,313 people reported to have side effects when taking Stavudine.
Among them, 12 people (0.12%) have Alpha 1 foetoprotein increased.

Could Stavudine cause Alpha 1 foetoprotein increased?

Among these 12 people:

What is the gender of people who have Alpha 1 foetoprotein increased when taking Stavudine? *

  • female: 50 %
  • male: 50 %

What is the age of people who have Alpha 1 foetoprotein increased when taking Stavudine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 41.67 %
  • 30-39: 58.33 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Stavudine? *

  1. Didanosine: 7 people, 58.33%
  2. Lamivudine: 5 people, 41.67%
  3. Viracept: 4 people, 33.33%
  4. Efavirenz: 3 people, 25.00%
  5. Crixivan: 3 people, 25.00%
  6. Atovaquone: 3 people, 25.00%
  7. Zidovudine: 2 people, 16.67%
  8. Nevirapine: 2 people, 16.67%
  9. Agenerase: 2 people, 16.67%
  10. Viramune: 1 person, 8.33%

What are other side effects people have besides Alpha 1 foetoprotein increased? *

  1. Liver Function Tests Nos Abnormal: 3 people, 25.00%
  2. Stillbirth (a birth of dead foetus): 2 people, 16.67%
  3. Ascites (accumulation of fluid in the abdominal cavity): 2 people, 16.67%
  4. Blood Bilirubin Increased: 2 people, 16.67%
  5. Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 2 people, 16.67%
  6. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 16.67%
  7. Hyperbilirubinaemia (excess of bilirubin in the blood): 1 person, 8.33%
  8. Hepatomegaly (abnormal enlargement of the liver): 1 person, 8.33%
  9. Hepatocellular Damage (liver damage): 1 person, 8.33%
  10. Hepatitis C Rna Positive: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Stavudine and have Alpha 1 foetoprotein increased?

- Check whether Alpha 1 foetoprotein increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Stavudine:

Alpha 1 foetoprotein increased treatments and more:

How severe was Alpha 1 foetoprotein increased and when was it recovered:

Expand to all the drugs that have ingredients of stavudine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Stavudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Alpha 1 foetoprotein increased:

Browse all the conditions that are associated with Alpha 1 foetoprotein increased:


How the study uses the data?

The study uses data from the FDA. It is based on stavudine (the active ingredients of Stavudine) and Stavudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: